​

Funding Round

Post-IPO Equity - 23andMe

Post-IPO Equity - 23andMe

Investment Firm

Overview

23andMe is a DNA testing technology company that enables its users to access their ancestry, genealogy, and inherited traits.

Announced Date

Jun 17, 2021

Funding Type

Post Ipo Equity

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

6

Investor Name
Participant InvestorForesite Capital
Participant InvestorRichard Branson
Participant InvestorAnne Wojcicki
Participant InvestorAltimeter Capital
Participant InvestorFidelity

Round Details and Background

23andMe raised $250000000 on 2021-06-17 in Post-IPO Equity

23andMe is a DNA testing technology company that enables its users to access their ancestry, genealogy, and inherited traits.

Company Funding History

14

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 07, 2011
Series C - 23andMe
2-9.0M
Nov 09, 2010
Series C - 23andMe
3-22.2M
Jun 18, 2009
Series B - 23andMe
3-13.6M
Oct 03, 2007
Series A - 23andMe
6-9.0M

Recent Activity

There is no recent news or activity for this profile.